Cosmecca Korea Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	772,052	640,929	524,329	470,719	399,399	396,466
Other Revenue	-	-	-0	-0	-0	-
Revenue	772,052	640,929	524,329	470,719	399,399	396,466
Revenue Growth	44.29%	22.24%	11.39%	17.86%	0.74%	16.93%
Cost of Revenue	590,350	483,513	400,197	364,168	334,958	324,578
Gross Profit	181,701	157,416	124,132	106,551	64,441	71,888
Selling, General & Admin	55,882	53,208	40,093	36,341	33,736	31,430
Research & Development	17,472	16,871	13,813	13,338	13,628	11,793
Amortization of Goodwill & Intangibles	489.43	567.5	3,081	2,987	2,917	2,848
Other Operating Expenses	1,409	1,411	1,072	1,034	807.14	1,049
Operating Expenses	82,069	73,880	63,769	57,397	54,074	51,833
Operating Income	99,632	83,537	60,362	49,154	10,367	20,055
Interest Expense	-5,453	-3,543	-3,197	-4,021	-3,672	-2,964
Interest & Investment Income	1,369	1,020	873.42	313.33	121.13	34.97
Earnings From Equity Investments	-323	-208.43	-147.09	264.96	-81.21	-56.99
Currency Exchange Gain (Loss)	11,566	-313.21	9,242	-24.62	-92.26	2,859
Other Non Operating Income (Expenses)	-113.93	-918.07	684.66	-19.93	500.34	749.26
EBT Excluding Unusual Items	106,678	79,575	67,818	45,667	7,143	20,677
Gain (Loss) on Sale of Investments	30.81	22.39	34.5	107.79	61.86	632.03
Gain (Loss) on Sale of Assets	-9.44	-12.92	8.68	327.31	-608.14	-1,671
Asset Writedown	-1,696	-1,696	-266.87	-	-224.1	-367.97
Other Unusual Items	-	-	-	-	-	-1,755
Pretax Income	105,003	77,888	67,594	46,102	6,373	17,514
Income Tax Expense	27,268	20,049	13,906	12,215	370.12	546.83
Earnings From Continuing Operations	77,735	57,838	53,688	33,887	6,003	16,967
Minority Interest in Earnings	-13,911	-12,399	-10,888	-11,568	-3,347	-8,063
Net Income	63,824	45,440	42,800	22,319	2,656	8,904
Net Income to Common	63,824	45,440	42,800	22,319	2,656	8,904
Net Income Growth	71.44%	6.17%	91.76%	740.32%	-70.17%	239.62%
Shares Outstanding (Basic)	11	11	11	11	11	11
Shares Outstanding (Diluted)	11	11	11	11	11	11
Shares Change	-	-	-	-	-	-
EPS (Basic)	5976.04	4254.67	4007.50	2089.82	248.69	833.71
EPS (Diluted)	5976.04	4254.67	4007.50	2089.82	248.69	833.71
EPS Growth	71.46%	6.17%	91.76%	740.32%	-70.17%	239.62%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	6,029	-6,342	20,803	23,400	5,115	-1,091
Free Cash Flow Per Share	564.48	-593.81	1947.85	2191.02	478.95	-102.17
Dividend Per Share	370.000	370.000	-	-	-	-
Dividend Growth	-	-	-	-	-	-
Gross Margin	23.54%	24.56%	23.67%	22.64%	16.13%	18.13%
Operating Margin	12.90%	13.03%	11.51%	10.44%	2.60%	5.06%
Profit Margin	8.27%	7.09%	8.16%	4.74%	0.66%	2.25%
Free Cash Flow Margin	0.78%	-0.99%	3.97%	4.97%	1.28%	-0.27%
EBITDA	117,356	100,049	78,161	65,926	27,091	36,463
EBITDA Margin	15.20%	15.61%	14.91%	14.01%	6.78%	9.20%
D&A For EBITDA	17,723	16,512	17,798	16,772	16,724	16,408
EBIT	99,632	83,537	60,362	49,154	10,367	20,055
EBIT Margin	12.90%	13.03%	11.51%	10.44%	2.60%	5.06%
Effective Tax Rate	25.97%	25.74%	20.57%	26.50%	5.81%	3.12%
Advertising Expenses	-	708.83	566.4	360.86	162.32	236.33